Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATFurniture, Fixtures and OtherGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Hinge Health (HNGE) Shares Outstanding (2023 - 2026)

Hinge Health's Shares Outstanding history spans 3 years, with the latest figure at $78.7 million for Q3 2025.

  • On a quarterly basis, Shares Outstanding rose 384.13% to $78.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $78.7 million, a 384.13% increase, with the full-year FY2024 number at $16.4 million, up 2.65% from a year prior.
  • Shares Outstanding hit $78.1 million in Q2 2025 for Hinge Health, up from $16.4 million in the prior quarter.
  • Over the last five years, Shares Outstanding for HNGE hit a ceiling of $78.1 million in Q2 2025 and a floor of $16.0 million in Q4 2023.
  • Historically, Shares Outstanding has averaged $28.6 million across 3 years, with a median of $16.3 million in 2024.
  • Biggest five-year swings in Shares Outstanding: grew 2.65% in 2024 and later skyrocketed 384.13% in 2025.
  • Tracing HNGE's Shares Outstanding over 3 years: stood at $16.0 million in 2023, then increased by 2.65% to $16.4 million in 2024, then surged by 380.58% to $78.7 million in 2025.
  • Business Quant data shows Shares Outstanding for HNGE at $78.7 million in Q3 2025, $78.1 million in Q2 2025, and $16.4 million in Q4 2024.